Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459576 · ClinicalTrials.gov registry record
Risk of Asthma in Infants With Atopic Dermatitis
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 120
- Enrollment target
NCT00459576: Completed study, sponsored by Indiana University.
NCT00459576 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00459576 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Infants will be enrolled in this study if they have never been diagnosed with asthma or wheezing and have been diagnosed with atopic dermatitis or eczema. Infants with some types of skin rashes are at high risk for developing asthma by 6 years of age. The purpose of this study is to determine whether we can identify infants who will develop asthma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2005-05 |
| Est. Completion | 2012-12 |
What the finished NCT00459576 record still lists
NCT00459576 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00459576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00459576 about?
NCT00459576 is a clinical study titled "Risk of Asthma in Infants With Atopic Dermatitis". Infants will be enrolled in this study if they have never been diagnosed with asthma or wheezing and have been diagnosed with atopic dermatitis or eczema. Infants with some types of skin rashes are at high risk for developing asthma by 6 years of age. The purpose of this study is to determine whethe...
What is the current status of trial NCT00459576?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2005-05. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT00459576?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia